None listed
Conditions
Interventions
None listed
Sponsors
Hanyang University Seoul Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients hospitalized for cholecystectomy due to a benign disease of the gallbladder (gallstone or gallbladder polyp) 2. 19 to 80
Exclusion criteria
Exclusion criteria: 1. For acute cholecystitis, grade II & III of Tokyo guideline 2018 2. In case of acute cholecystitis, hepatitis level is more than 5 times the upper limit of normal. 3. When jaundice level is more than 3 times the normal upper limit due to acute inflammation 4. If there is a tendency to hemorrhage due to prothrombin time less than 50,000 prolonged 1.5 times or more 5. In the past 2 years, alcoholic liver disease is suspected with a weekly alcohol consumption of 210g or more in men and 140g or more in women. 6. A case of liver disease caused by chronic hepatitis B or C 7. If you have a history of taking medications that can cause fatty liver A. Glucocorticoid B. Tamoxifen C. Methotrexate D. Valproate E. Amiodarone F. 5-fluorouracil G. Irinotecan H. Highly active antiretroviral therapy (HARRT) 8. If you have a genetic disease that causes fatty liver A. Abetalipoproteinemia B. Familial hypobetalipoproteinemia C. Familial combined hyperlipidemia D. Glycogen storage disease E. Lipodystrophy F. Weber-Christian disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biomarker | — |
Secondary
| Measure | Time frame |
|---|---|
| Bile acid composition | — |
Countries
Korea, Republic of
Contacts
Public ContactDeawon Jun
Hanyang University
Outcome results
None listed